Does LUBIPROSTONE Cause Off label use? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Off label use have been filed in association with LUBIPROSTONE (Amitza). This represents 3.1% of all adverse event reports for LUBIPROSTONE.
37
Reports of Off label use with LUBIPROSTONE
3.1%
of all LUBIPROSTONE reports
3
Deaths
17
Hospitalizations
How Dangerous Is Off label use From LUBIPROSTONE?
Of the 37 reports, 3 (8.1%) resulted in death, 17 (45.9%) required hospitalization, and 1 (2.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUBIPROSTONE. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does LUBIPROSTONE Cause?
Diarrhoea (170)
Drug ineffective (131)
Nausea (110)
Constipation (82)
Vomiting (75)
Dizziness (59)
Abdominal distension (57)
Dyspnoea (53)
Headache (47)
Abdominal pain (45)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LUBIPROSTONE Alternatives Have Lower Off label use Risk?
LUBIPROSTONE vs LUCENTIS
LUBIPROSTONE vs LUCRIN DEPOT
LUBIPROSTONE vs LUMASIRAN
LUBIPROSTONE vs LUMATEPERONE
LUBIPROSTONE vs LUMIGAN